“…The same strategy should be feasible for other lipids, such as sphingolipids (Dadsena et al, 2019), phospholipids and lysophospholipids (Xia and Peng, 2013;Peng et al, 2014), endocannabinoids (Dixon et al, 2012), or fatty acid metabolites for residue-level identification of binding sites. Developing new reagents with optimal photochemistry, especially the use of trifluoromethylphenyl diazirine (TPD) photoreactive groups, may be essential for this effort (Cheng et al, 2019;Dietzen et al, 2021;Krishnan et al, 2021). Once a site(s) is identified, competition photolabeling experiments with any lipid or ligand can be used to determine relative binding affinities at individual sites as well as state-dependent changes in binding affinity, as has extensively applied for anesthetic binding sites in the GABA A R (Li et al, 2010;Chiara et al, 2013;Jayakar et al, 2014Jayakar et al, , 2019.…”